Physician profile
Patrick Ryan Gamblin
NPI 1154870491
$1,729.18
in general payments reported to CMS, 2019-2025
18 companies · $93.27 in 2025
The $93.27 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $171 · 2022: $259 · 2023: $365 · 2024: $840 · 2025: $93.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $728.77 | 2021-2025 | Trigen Intertan, Evos, Intellio Link Werewolf |
| Horizon Therapeutics Plc | $152.80 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $144.94 | 2024 | A.L.P.S., Dvr Anatomic Kickstand |
| Fidia Pharma USA INC. | $100.12 | 2023 | Triluron, Hymovis |
| Medical Device Business Services, INC. | $97.18 | 2024 | Stratafix |
| Joint Restoration Foundation, INC. | $82.97 | 2024 | |
| Baxter Healthcare | $67.25 | 2021-2023 | Floseal |
| Heron Therapeutics, INC. | $65.13 | 2021-2023 | Aponvie |
| Avanos Medical | $59.12 | 2023-2024 | Trivisc Sodium Hyaluronate |
| Depuy Synthes Sales INC. | $43.99 | 2022-2025 | Monovisc, Orthovisc |
| Boston Scientific Corporation | $38.59 | 2024 | |
| Ethicon US, LLC | $29.43 | 2021 | |
| Abbott Laboratories | $27.78 | 2022-2023 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $26.62 | 2022 | |
| Davol INC. | $20.11 | 2023 | Arista Ah Flexitip |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $15.68 | 2024 | Activ.A.C., Prevena |
| Vertex Pharmaceuticals Incorporated | $15.26 | 2025 | |
| Abbvie INC. | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gamblin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.